Immunodiagnosis of platelet activation in immune thrombocytopenia through scFv antibodies cognate to activated IIb3 integrins

References

• McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol 2007; 44:S3-S11; PMID:18096470; http://dx.doi.org/10.1053/j.seminhematol.2007.11.002
   PubMed Web of Science ®Google Scholar
• McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol 2000; 37(3):239-48; PMID:10942218; http://dx.doi.org/10.1016/S0037-1963(00)90102-1
   PubMed Web of Science ®Google Scholar
• Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci 1998; 19:237-44; PMID:10351135; http://dx.doi.org/10.1016/S0955-3886(98)00037-X
   PubMedGoogle Scholar
• Hou M(1), Stockelberg D, Kutti J, Wadenvik H. Antibodies against platelet GPIb/IX, GPIIb/IIIa, and other platelet antigens in chronic idiopathic thrombocytopenic purpura. Eur J Haematol 1995; 55:307-14; PMID:7493677; http://dx.doi.org/10.1111/j.1600-0609.1995.tb00702.x
   PubMed Web of Science ®Google Scholar
• Iraqi M, Perdomo J, Yan F, Choi P, Chong BH. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Haematologica 2015; 100:623-32; PMID:25682608; http://dx.doi.org/10.3324/haematol.2014.115634
   PubMed Web of Science ®Google Scholar
• Lev PR, Grodzielski M, Goette NP, Glembotsky AC, Espasandin YR, Pierdominici MS, Contrufo G, Montero VS, Ferrari L, Molinas FC, Heller PG, Marta RF. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count. Br J Haematol 2014; 165:854-64; PMID:24673454; http://dx.doi.org/10.1111/bjh.12832
   PubMed Web of Science ®Google Scholar
• Bhoria P, Sharma S, Varma N, Malhotra P, Varma S, Luthra-Guptasarma M. Effect of steroids on the activation status of platelets in patients with Immune thrombocytopenia (ITP). Platelets 2015; 26:119-26; PMID:24617442; http://dx.doi.org/10.3109/09537104.2014.888546
   PubMed Web of Science ®Google Scholar
• Schwab C, Bosshard HR. Caveats for the use of surface-adsorbed protein antigen to test the specificity of antibodies. J Immunol Methods 1992; 147:125-34; PMID:1311735; http://dx.doi.org/10.1016/S0022-1759(12)80037-8
   PubMed Web of Science ®Google Scholar
• Jacobin MJ, Robert R, Pouns O, Laroche-Traineau J, Nurden A, Peter K, Little M, Clofent-Sanchez G. Improving selection of alphaIIbbeta3-binding phage antibodies with increased reactivity derived from immunized donors. Clin Immunol 2003; 108:199-210; PMID:14499243
   PubMed Web of Science ®Google Scholar
• Fullard JF. The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm Des 2004; 10:1567-76; http://dx.doi.org/10.2174/1381612043384682
   PubMed Web of Science ®Google Scholar
• Bennett JS. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005; 115:3363-9; PMID:16322781; http://dx.doi.org/10.1172/JCI26989
   PubMed Web of Science ®Google Scholar
• Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004; 104:1606-15; PMID:15205259; http://dx.doi.org/10.1182/blood-2004-04-1257
   PubMed Web of Science ®Google Scholar
• Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993; 7:52-62; PMID:8467233; http://dx.doi.org/10.1016/0268-960X(93)90024-X
   PubMed Web of Science ®Google Scholar
• McEver RP, Bennett EM, Martin MN. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies. J Biol Chem 1983; 258:5269-75; PMID:6220015
   PubMed Web of Science ®Google Scholar
• Newman PJ, Allen RW, Kahn RA, Kunicki TJ. Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood 1985; 65:227-32; PMID:3155488
   PubMed Web of Science ®Google Scholar
• Chen P, Sun CX, Liu JN. A novel anti-platelet monoclonal antibody (3C7) specific for the complex of integrin alpha IIb beta3 inhibits platelet aggregation and adhesion. J Biol Chem 2005; 280:25403-8; PMID:15890654; http://dx.doi.org/10.1074/jbc.M500462200
   PubMed Web of Science ®Google Scholar
• McMillan R, Lopez-Dee J, Loftus JC. Autoantibodies to alpha(IIb)beta(3) in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on alpha(IIb). Blood 2001; 97:2171-2; PMID:11264188; http://dx.doi.org/10.1182/blood.V97.7.2171
   PubMed Web of Science ®Google Scholar
• Bednar RA, Gaul SL, Hamill TG, Egbertson MS, Shafer JA, Hartman GD, Gould RJ, Bednar B. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets. J Pharmacol Exp Ther 1998; 285:1317-26; PMID:9618439
   PubMed Web of Science ®Google Scholar
• Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117:4190-207; PMID:21325604; http://dx.doi.org/10.1182/blood-2010-08-302984
   PubMed Web of Science ®Google Scholar
• Sharma R, Vasishta RK, Sen RK, Luthra-Guptasarma M. Refolding of HLA-B27 heavy chains in the absence of beta2m yields stable high molecular weight (HMW) protein forms displaying native-like as well as non-native-like conformational features: implications for autoimmune disease. BiochimBiophysActa 2007; 1772:1258-69; PMID:18036353
   PubMed Web of Science ®Google Scholar
• Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, Chen YC, Hagemeyer CE, Ahrens I, Moran N, Kenn D. et al. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ Res 2006; 99:25-33; PMID:16778135; http://dx.doi.org/10.1161/01.RES.0000232317.84122.0c
   PubMed Web of Science ®Google Scholar